Canada markets closed

DYN Jun 2024 30.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
1.05000.0000 (0.00%)
At close: 09:47AM EDT
Full screen
Previous Close1.0500
Open1.0500
Bid0.6500
Ask1.3500
Strike30.00
Expire Date2024-06-21
Day's Range1.0500 - 1.0500
Contract RangeN/A
Volume1
Open Interest990
  • GlobeNewswire

    Dyne Therapeutics to Present at Jefferies Global Healthcare Conference

    WALTHAM, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to participate in a fireside chat at the Jefferies Global Healthcare Conference in New York on Thursday, June 6, 2024 at 3:00 p.m. ET. A live webcast will be available in the Investors & Media section of Dyne’s w

  • GlobeNewswire

    Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

    WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the closing of its previously announced underwritten public offering of 12,075,000 shares of its common stock at a public offering price of $31.00 per share, which includes 1,575,000 shares issued upon the exercise in full by the underwriters

  • GlobeNewswire

    Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock

    WALTHAM, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the pricing of an underwritten public offering of 10,500,000 shares of its common stock at a public offering price of $31.00 per share. The gross proceeds to Dyne from the offering, before deducting underwriting discounts and commissions and